share_log

Marpai | 8-K: MARPAI reports Third QUARTER 2024 financial results

Marpai | 8-K: MARPAI reports Third QUARTER 2024 financial results

Marpai | 8-K:MARPAI 公布 2024 年第三季度财务业绩
美股SEC公告 ·  2024/11/13 00:41

Moomoo AI 已提取核心信息

Marpai reported Q3 2024 financial results showing continued progress in its turnaround efforts despite revenue challenges. Net revenues decreased 20% YoY to $7.0 million, while operating loss improved significantly, dropping 57% YoY to $3.1 million. Operating expenses were reduced by 36% YoY to $10.1 million.The company's net loss narrowed to $3.6 million, a 51% improvement YoY, with basic and diluted earnings per share of ($0.30), up $0.68 per share compared to Q3 2023. CEO Damien Lamendola emphasized the company's focus on achieving profitability and positive cash flow, hinting at upcoming developments in Q4 2024.As of September 30, 2024, Marpai maintained $830,000 in cash and cash equivalents, with $11 million in restricted cash. The company operates as a technology platform in the $22 billion TPA market, serving self-funded employer health plans through its subsidiaries.
Marpai reported Q3 2024 financial results showing continued progress in its turnaround efforts despite revenue challenges. Net revenues decreased 20% YoY to $7.0 million, while operating loss improved significantly, dropping 57% YoY to $3.1 million. Operating expenses were reduced by 36% YoY to $10.1 million.The company's net loss narrowed to $3.6 million, a 51% improvement YoY, with basic and diluted earnings per share of ($0.30), up $0.68 per share compared to Q3 2023. CEO Damien Lamendola emphasized the company's focus on achieving profitability and positive cash flow, hinting at upcoming developments in Q4 2024.As of September 30, 2024, Marpai maintained $830,000 in cash and cash equivalents, with $11 million in restricted cash. The company operates as a technology platform in the $22 billion TPA market, serving self-funded employer health plans through its subsidiaries.
Marpai公布了2024年第三季度的财务业绩,显示尽管营业收入面临挑战,但在扭转局面方面取得了持续进展。净营业收入同比减少20%至700万美元,而营业亏损明显改善,同比下降57%至310万美元。营业费用同比减少36%至1010万美元。公司的净亏损收窄至360万美元,同比改善51%,基本和稀释每股收益为($0.30),与2023年第三季度相比每股上涨$0.68。首席执行官达米恩·拉门多拉强调公司专注于实现盈利和正现金流,并暗示2024年第四季度将有新发展。截至2024年9月30日,Marpai持有现金及现金等价物83万美元,受限制现金为1100万美元。该公司在220亿美元的TPA市场作为科技平台运营,通过其子公司为自资雇主健康计划提供服务。
Marpai公布了2024年第三季度的财务业绩,显示尽管营业收入面临挑战,但在扭转局面方面取得了持续进展。净营业收入同比减少20%至700万美元,而营业亏损明显改善,同比下降57%至310万美元。营业费用同比减少36%至1010万美元。公司的净亏损收窄至360万美元,同比改善51%,基本和稀释每股收益为($0.30),与2023年第三季度相比每股上涨$0.68。首席执行官达米恩·拉门多拉强调公司专注于实现盈利和正现金流,并暗示2024年第四季度将有新发展。截至2024年9月30日,Marpai持有现金及现金等价物83万美元,受限制现金为1100万美元。该公司在220亿美元的TPA市场作为科技平台运营,通过其子公司为自资雇主健康计划提供服务。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息